EIC Accelerator for novel Breast tumor removal technology
| Reference number | |
| Coordinator | Resitu Medical AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | September 2023 - July 2024 |
| Status | Completed |
| Venture | Preparation projects for international application within health |
| Call | Preparation project for international proposal in health and food 2023 |
Important results from the project
The purpose of the project is to prepare and submit a successful grant proposal to EIC accelerator for the development and commercialization of an approved series of instruments with different diameters for removal of breast abnormalities.
Expected long term effects
An approved EIC proposal for a grant of 2.35 M EURO and an investment of 5M Euro.
Approach and implementation
The work is done by the Resitu team in collaboration with consultants. It will consist of 3 stages: 1. Development of EIC Short appliction: Completed and submitted 2. Development of EIC full application: Ongoing, to be submitted 3 October 2024 if EIC Short application is successful 3. Preparation for EIC stage 3 interview. To be initiated after full application approval.